CKD In Primary Care Dr Mohammed Javid.

Slides:



Advertisements
Similar presentations
Chronic kidney disease
Advertisements

Chronic kidney disease
Hisham Abdelwahab MRCP U.K MMed/SCI
Proteinuria and Haematuria – an update Alex Heaton
CKD ML/LH What are people hoping to cover from the session today?
Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
RENAL DISEASE – A GENERAL PRACTICE PERSPECTIVE Dr Shareen Hallas.
SLOW- COOKING THE BEANS “OR, HOW TO STOP WORRYING AND APPLY SOME LOVE TO THE KIDNEYS” AN APPROACH TO CKD SARA KATE LEVIN, MD JANUARY 2014.
General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
Progressive Chronic Kidney Disease Cherelle Fitzclarence August 2009.
National Institute for Health and Clinical Excellence.
18 week commissioning pathways for kidney disease and renal transplantation Specialty Clinical Leads Lawrence Goldberg: CKD and ESRF pathways John Scoble:
Hypertension and chronic kidney disease in older people Dr Rick Fielding Consultant Renal Medicine Brighton & Sussex University Hospitals.
Cardiovascular Hot topics Dr Saqib Mahmud, MRCP(UK)
Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
RENAL BLOOD TESTS WHAT DO THEY MEAN, WHERE TO GO FOR WHAT TO DO.
Chronic Kidney Disease NICE Guidelines 2008 Dr Jennifer Kuo Dr Naeema Rashid Dr Shamita Das.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Chronic Kidney Disease Workshop Maarten Taal Department of Renal Medicine Derby City General Hospital Derby Nephrology Research.
Chronic Kidney Disease Jacqueline Annand – CKD Nurse Mary Simpson – CKD Nurse Joyce Mackie – Pre Dialysis/Transplant liaison Sister.
Lesley Stevens MD Tufts-New England Medical Center
CHRONIC KIDNEY FAILURE
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
BY: DR. NAUSHAD PERVEZ.  Chronic Kidney Disease (CKD)
Everything you wanted to know about CKD SUE GILDERSLEVE RENAL NURSE SPECISLIST.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
CKD: the primary/secondary care interface Daniel Ford Consultant Renal Physician UHCW.
RENAL DISEASE IN DIABETES
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
An update on chronic renal failure: follow-up and when to refer ? Assoc Prof Johan Rosman Renal Department Waitemata DHB
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
Section 6: Management in primary care Particular emphasis on nurse practitioner’s role.
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
QOF 2009 RBW 11/08. Summary of 2009 Heart Failure and beta blockade CKD and proteinuria Contraception Anxiety and depression New diabetes HbA1c targets.
SHEFFIELD GUIDELINES: RENAL DISEASE IN DIABETES Dr Jenny Stephenson GP, Stannington Medical Centre
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
The management of renal problems in primary care Hugh Gallagher Consultant Nephrologist St Helier Hospital.
CKD update Dr Saqib Mahmud MRCP(UK),MRCGP. Chronic kidney disease Defined by a reduced eGFR, proteinuria, haematuria and/ or structural abnormalities.
Section 5: Configuration of healthcare to manage CKD.
All things Renal Peer Support Zoulikha Zair. RAAS.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Hypertension Dr Nidhi Bhargava 8/10/13. Why Treat Increased risk of cardiovascular death and mortality Increased systolic, diastolic and pulse pressures.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Project supported by A Package of Innovation for Managing kidney disease in primary care Registered Office: Nene Hall, Lynch Wood Park, Peterborough PE2.
Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
What is PD2010_023 Policy Directive from NSW DOH, 15th April 2010
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Predicting Progression in Diabetic Nephropathy: New Biomarker: sTNFR1* Circulating soluble Tumor Necrosis Factor Receptor 1.
NICE/BHS Hypertension Guideline Review 28 June 2006 John Barker ESH Clinical Hypertension Specialists European Society of Hypertension Specialist Accreditation.
CHRONIC KIDNEY DISEASE
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
NICE CKD Guideline Update Karen Jenkins Consultant Nurse Chair Kent & Medway Renal Collaborative Kent Kidney Care Centre EKHUFT.
Diabetes and the Kidney Richard Kingston Department of Renal Medicine Kent and Canterbury Hospital.
NICE Chronic Kidney Disease (CKD) Guidance 2014 Chronic kidney disease in adults: assessment and management (CG182)
Sheffield Kidney Institute Global Kidney Academy CKD Micro-Lecture Epidemiology, Screening and Guidelines Professor Meguid El Nahas, PhD, FRCP Sheffield.
National service framework for Renal
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Section 4: Managing progression of CKD
Section 6: Management in primary care
Multimorbidity and diabetes - what to do?
Chapter 1: CKD in the General Population
Test.
MANAGING KIDNEY DISEASE IN PRIMARY CARE
Chapter 1: CKD in the General Population
Section 5: Configuration of healthcare to manage CKD
Multimorbidity and diabetes - what to do?
Presentation transcript:

CKD In Primary Care Dr Mohammed Javid

Relevance End Stage CKD places a very significant burden on patients quality of life. End Stage CKD is very expensive to manage. Deteriorating CKD is an independant risk factor for an increase in mortality from cardiovascular disease. QOF: CKD = 38 points

Guidelines National Service Framework 2004 -2005 NICE guidelines 2008 PACE local guidelines QOF

eGFR CKD classification is based on eGFR Estimates Glomerular Filtration Rate using serum creatinine and patients Age, Sex, etc Cockroft-Gault formula MDRD formula

Creatinine 120 eGFR 31-40 eGFR 82-106

CKD stage GFR (ml/min/1.73m2) Description 1 >90 2 60-89 3 30-59 4 Normal renal function but other evidence of organ damage* 2 60-89 Mild reduction in renal function with other evidence of organ damage* 3 30-59 Moderately reduced GFR 4 15-29 Severely reduced GFR 5 <15 End stage, or approaching, end stage renal failure Insert P for proteinuria 3a and 3b 45-49 and 30-44 * Structural (eg APCKD), functional (eg proteinuria) or biopsy proven GN

Risks of a low eGFR Renal 1% of patients with CKD 3 will progress to ERF in their lifetime (99% won’t) Cardiovascular If you have an eGFR <60 you are at higher risk of all cause mortality and any cardiovascular event eGFR is presently being used as a screening test for CKD but it has some limitations. What is not clear is whether it is the low eGFR that increases your risk, or whther it is a marker of other co-morbidities.

100 patients with eGFR < 60

1 year later: 1 patient needs RRT, 10 patients have died (> 50% CV death)

10 years later: 8 patients need RRT, 65 patients have died, 27 have ongoing CKD

Proteinuria Indicates poorer renal prognosis Urine dipstick Protein : Creatinine ratio PCR Protein : Creatinine Index PCI Albumin : Creatinine Ratio ACR Early morning sample <5 normal, >30 significant , >70 severe Check for heamaturia

Progressive CKD Check at least 3 eGFRs over 90 days Defined as a decline in eGFR of >5 within 1 year, or >10 within 5 years

Routine management Lifestyle modification Smoking increases risk of progressive CKD Lose weight if obese Regular exercise Reduce salt if hypertensive

Routine management Monitor eGFR CKD 3 6 monthly CKD 4 3 monthly CKD 5 6 weekly We have 5 patients with CKD 4 or 5 who have no hospital input and where there is no recall arrangements

Routine management Control BP NICE target <140/90 <130/80 if ACR >70 <130/80 if diabetic QOF <140/85 for all

Routine management ACEI or ARB: Diabetes + ACR (>30) (irrespective of hypertension or CKD stage) Non-Diabetic with CKD + HT + ACR >30 Non-Diabetic with CKD + ACR >70 (irrespective of presence of HT or CVD)

Routine management Routine anti-hypertensive treatment Non-diabetic + CDK + HT + ACR <30 (See NICE Hypertension guideline 34)

Routine management CVD risk assessment treat with a statin if CVD risk >20% (SystmOne CVD risk calculator does NOT include adjustment for chronic renal disease, but QRISK2 does) Immunizations Influenza - annually Pneumococcal - 5 yearly, due to declining antibody levels 5/16 CKD 4-5 have CVD risks >30 and are not on a statin

Routine management Drugs Check BNF Appendix 3: Renal Impairment Test for anaemia If Hb <11 first consider other causes of anaemia Determine iron status – if serum ferritin <100 start oral iron 10% of those with KD4 have anaemia and 4% of those with CKD3B Rates are a lot higher in diabetics with CKD-aprox 22% will be anaemic. ESA’s tend to be initiated in hospital and then administered at the practice.

Consider renal USS If CKD 4 or 5 Progressive CKD Visible or persistent microhaematuria Symptoms of urinary tract obstruction FHx polycystic kidney disease and >20yrs of age

Consider referral CKD 4 or 5 Proteinuria ACR >70 Proteinuria ACR>30 with haematuria Progressive CKD CKD and poorly controlled BP on 4 agents Suspected genetic renal disease or renal artery stenosis We have 5 patients CKD 4/5 who have not been referred for renal opinion –may be legitimate reasons age/co morbidities etc

QOF indicators CKD points total = 38 points = £££ CKD1 (register) = 6 points CKD2 (bp checked) = 6 points CKD3 (bp controlled) = 11 points CKD5 (acei started) = 9 points CKD6 (acr checked) = 6 points

Take Home Message CKD is an independant risk factor for cardiovascular mortality which far outweighs the risk of developing end-stage renal disease CKD 3 is managed in primary care with ACE-i and cardiovascular optimisation. Monitor eGFR Blood pressure control with ACE Check for proteinuria